Matt Gunnison currently serves as the Chief Executive Officer at Biosynth, a KKR portfolio company specializing in pharmaceutical and diagnostics supply chains. They previously held the position of Chief Executive Officer at Gamma Biosciences from 2019 to 2024, where they oversaw investments in advanced therapy companies. Matt also gained valuable experience as Managing Director at GE Ventures from 2014 to 2016 and served as an Associate in Corporate M&A at Sidley Austin LLP between 2007 and 2011. They completed a JD at the University of Michigan Law School and an AB in Economics at Georgetown University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices